Hsiri Therapeutics
Media, Pennsylvania, United States
About Hsiri Therapeutics
Hsiri Therapeutics is a development stage pharmaceutical company engaged in the discovery and development of new antibiotics to treat diseases caused by drug resistant bacteria. Hsiri Therapeutics’ efforts are primarily directed at two discrete groups of pathogens – mycobacterial diseases and gram-negative infections. Hsiri Therapetics was formed based on the antibiotic research that originated in the laboratories of Professor Marvin Miller at the University of Notre Dame.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Last round: Series Unknown (Dec 2015)
- Website: hsiritherapeutics.com
- Phone: (484) 445-4296
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/hsiri-therapeutics-2460029 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.